[Adoptive immunotherapy of malignant diseases using normal allogeneic LAK cells].
Allogeneic LAK cells induced from PBL of normal donors were used for adoptive immunotherapy of malignant diseases. The possibility of an antibody against allogeneic LAK cells was suggested. However, no immune reaction was observed and LAK activity was maintained in vitro in the presence of patient's plasma sampled during the course of therapy.
D006087:Graft vs Host Reaction; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000637:transplantation*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2